 |
|
|
| Chronic Myeloproliferative Disorders |
| Date: | Saturday, 14 June 2003 |
| Time: | 08:30-09:45 |
| Room: | Room B (outside Halle Tony Garnier) |
| 08:30-08:45 |
0421 |
|
|
THE UTILITY OF IN VITRO TESTING FOR IMATINIB SENSITIVITY IN BCR-ABL NEGATIVE MYELOPROLIFERATIVE DISORDERS.
N.C.P. Cross, A. Chase, B. Schultheis, R.V. Seear, J. Baxter, J. Thaler, T. Kuhr, J.F. Apperley, J.V. Melo (Salisbury, United Kingdom)
| 08:45-09:00 |
0422 |
|
|
ANAGRELIDE TREATMENT IN 167 PATIENTS WITH ESSENTIAL THROMBOCYTHAEMIA: A RETROSPECTIVE STUDY OF THE ITALIAN GROUP GIMMC
L. Gugliotta, A. Grossi, M.G. Mazzucconi, C. Beggi, S. Bulgarelli, R. Redi, F. Balestri, P.R. Scalzulli, P. Noris, A.M. Liberati, M. Spriano, A. Tabilio, B. Amato, A. Di Tucci, A. Candoni, F. Iuliano, E. Balleari, S. Sacchi, G. Gaidano, M. Giordano, A. Sciorio, G. Specchia, A. Andriani, E. Cacciola, R. Cacciola, V. Martinelli, S. Tringali, F. Lauria, A. Ciocca Vasino, M. Crugnola (Reggio Emilia, Italy)
| 09:00-09:15 |
0423 |
|
|
PROGNOSTIC SIGNIFICANCE OF BONE MARROW BIOPSY IN ESSENTIAL THROMBOCYTEMIA
C. Annaloro, F. Radaelli, C. Vener, E. Curioni, G. Lambertenghi Deliliers (Milano, Italy)
| 09:15-09:30 |
0424 |
|
|
THROMBOPOIETIN PARTIALLY CORRECTS THROMBOCYTOPENIA IN GATA-1LOW MICE WITHOUT INDUCING MYELOFIBROSIS PROGRESSION
A.M. Vannucchi, L. Bianchi, A. Pancrazzi, A.M. Laurenzana, F. Paoletti, R.A. Rana, L. Marsilli, R. Lorenzini, G. Migliaccio, A.R. Migliaccio (Florence, Italy)
| 09:30-09:45 |
0425 |
|
|
A PHASE II CLINICAL TRIAL OF LOW-DOSE THALIDOMIDE FOR MYELOFIBROSIS WITH MYELOID METAPLASIA
G. Barosi, M. Marchetti, B. Dupriez, J.L. Demory (Pavia, Italy)
|